Paul L Doering

Paul L Doering, M.S.

Distinguished Service Professor Emeritus

Department: Pharmaceutical Outcomes & Policy
Business Email: doering@cop.ufl.edu

About Paul L Doering

Doering is a Emeritus Distinguished Service Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida, College of Pharmacy. He is also Co-director of the statewide Drug Information and Pharmacy Resource Center.

Doering received his Bachelor of Science in Pharmacy from the University of Florida in 1972 and continued his training at the same institution, earning the Master of Science in Clinical Pharmacy in 1975.

Upon graduation, Doering accepted a position in the University’s Department of Medicine as a research assistant where he designed, implemented and evaluated a program of adverse drug reaction monitoring in the obstetric patient.

Current teaching responsibilities include: coordinating a Non-prescription Products course for undergraduate pharmacy students, a senior-level course in Pharmacotherapy, and an elective course in Drug Abuse. He also guest lectures in a variety of team taught courses in the College of Pharmacy and other Health Center colleges.

Doering has strong ties with the practice of pharmacy, having been a practicing pharmacist both in the hospital and community setting. A member of many local, state, and national pharmaceutical societies, he is a past-president of his local pharmacy association.

Doering has been recognized four times as Teacher of the Year. In March, 1990, he was awarded Fellowship status in the APhA’s Academy of Pharmacy Practice and Management. In 1993, he received one of two Teaching Incentive Awards given to UF College of Pharmacy faculty. In 1995, Doering was promoted to Distinguished Service Professor, the university’s highest honor awarded to a faculty member, he was the first professor in the College of Pharmacy to be recognized in this way.

Teaching Profile

Courses Taught
2006-2017
PHA5737 Drugs in Society
2006-2010,2014
PHA5784 Pharmacotherapy 4
2012-2014
PHA5226 Evidence-Base Pharmcy
2012-2014
PHA5719 Intro Quant Methods
2013
PHA5783 Pharmacotherapy 3
2012
PHA6796 Study Design in Pharmaceutical Outcomes & Policy Research
2007,2009-2011
PHA5787 Pharmacotherapy 5
2010
PHA5788 Pharmacotherapy 6
2010
PHA5907 Research in Phar Prac

Research Profile

Research Interests: Drug information, adverse drug reactions, drug interactions, toxicology of drug products, over-the-counter medicines, herbal medicines, drug effects on the fetus and neonate, innovative teaching methods

Publications

2013
Pseudoephedrine and false-positive immunoassay urine drug tests for amphetamine.
Pharmacotherapy. 33(5):e88-9 [DOI] 10.1002/phar.1216. [PMID] 23065913.
2009
Speaker evaluations: don’t you be the ugly one!
The Annals of pharmacotherapy. 43(2):360-2 [DOI] 10.1345/aph.1L557. [PMID] 19141653.
2008
Bioidentical hormone therapy: a panacea that lacks supportive evidence.
Current opinion in obstetrics & gynecology. 20(4):400-7 [DOI] 10.1097/GCO.0b013e3283081ae9. [PMID] 18660693.
2007
Buprenorphine for the treatment of opioid dependence.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 64(3):266-72 [PMID] 17244875.
2007
Prescribing authority for pharmacists, Florida style: a home run or a swing and a miss?
The Annals of pharmacotherapy. 41(11):1878-83 [PMID] 17895326.
2005
Acamprosate for the treatment of alcohol dependence.
Clinical therapeutics. 27(6):695-714 [PMID] 16117977.
2005
The Medicare Part D drug benefit: lessons from the experience with drug discount cards.
The American journal of geriatric cardiology. 14(6):308-12 [PMID] 16276128.
2005
Vitamin C and vitamin E for Alzheimer’s disease.
The Annals of pharmacotherapy. 39(12):2073-80 [PMID] 16227450.
2004
Bioidentical hormone therapy: a review.
Menopause (New York, N.Y.). 11(3):356-67 [PMID] 15167316.
2004
Evaluation of online drug references for identifying over-the-counter solid oral dosage forms.
Journal of the American Pharmacists Association : JAPhA. 44(6):694-9 [PMID] 15637852.
2003
Putting an Ecstasy test kit to the test: harm reduction or harm induction?
Pharmacotherapy. 23(10):1238-44 [PMID] 14594341.
2002
Cerivastatin and the dissemination of adverse event information.
The Annals of pharmacotherapy. 36(6):1099-103 [PMID] 12058704.
2002
Review of pregnancy labeling of prescription drugs: is the current system adequate to inform of risks?
American journal of obstetrics and gynecology. 187(2):333-9 [PMID] 12193921.
2001
FDA labeling system for drugs in pregnancy.
The Annals of pharmacotherapy. 35(11):1485-9 [PMID] 11724104.
2001
GHB: an important pharmacologic and clinical update.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 4(2):167-75 [PMID] 11466174.
2000
Effect of oral creatine supplementation on random urine creatinine, pH, and specific gravity measurements.
Clinical chemistry. 46(2):295-7 [PMID] 10657393.
1999
Discontinuation rates of Helicobacter pylori treatment regimens: a meta-analysis.
Pharmacotherapy. 19(3):324-32 [PMID] 10221370.
1997
Evaluation of electronic drug information resources for answering questions received by decentralized pharmacists.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 54(22):2592-6 [PMID] 9397221.
1995
Physicians’ perceptions and knowledge of drug costs: results of a survey.
Formulary (Cleveland, Ohio). 30(5):268-70, 272, 277 [PMID] 10151726.
1994
Use of nifedipine in the hypertensive diseases of pregnancy.
The Annals of pharmacotherapy. 28(12):1371-8 [PMID] 7696729.
1994
Using the “smart pill” to teach about substance abuse.
The Annals of pharmacotherapy. 28(3):390-1 [PMID] 8193432.
1993
Efficacy of nutritional supplements used by athletes.
Clinical pharmacy. 12(12):900-8 [PMID] 8137607.
1992
Drug-food interaction counseling programs in teaching hospitals.
American journal of hospital pharmacy. 49(4):855-60 [PMID] 1595722.
1992
Patterns of prescribing isotretinoin: focus on women of childbearing potential.
The Annals of pharmacotherapy. 26(2):155-61 [PMID] 1554922.
1990
Comparison of two self-instructional manuals on adverse drug reaction monitoring.
American journal of hospital pharmacy. 47(9):2062-4 [PMID] 2244946.
1990
Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
DICP : the annals of pharmacotherapy. 24(11):1078-83 [PMID] 2275233.
1990
Organization and operation of P & T Committees in the state of Florida: a survey.
Hospital formulary. 25(9):983-6, 988 [PMID] 10106259.
1989
Effects of cocaine on the human fetus: a review of clinical studies.
DICP : the annals of pharmacotherapy. 23(9):639-45 [PMID] 2678766.
1988
Formulary status of intravenous immunoglobulins in selected hospitals.
American journal of hospital pharmacy. 45(11):2377-9 [PMID] 3228096.
1988
Therapeutic substitution in the health maintenance organization outpatient environment.
Drug intelligence & clinical pharmacy. 22(2):125-30 [PMID] 3349928.
1987
Generic equivalence of dermatologic products. How equivalent is equivalent?
Journal of the American Academy of Dermatology. 16(5 Pt 1):1068-70 [PMID] 3584574.
1986
Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosing.
Drug intelligence & clinical pharmacy. 20(10):792-5 [PMID] 3769772.
1986
Missing: reports of clinical experiences with generic drugs.
Drug intelligence & clinical pharmacy. 20(9):675-6 [PMID] 3757776.
1986
Pharmacists as prescribers: the Florida experience.
Drug intelligence & clinical pharmacy. 20(12):983-4 [PMID] 3816551.
1986
Survey of the professional interrelations between dermatologist and pharmacist.
Drug intelligence & clinical pharmacy. 20(11):876-80 [PMID] 3780421.
1985
Clinical pharmacy services in Florida hospitals–1984.
American journal of hospital pharmacy. 42(7):1562-4 [PMID] 4025354.
1984
Effect of antacids on predicted steady-state cimetidine concentrations.
Digestive diseases and sciences. 29(5):385-9 [PMID] 6714054.
1984
Therapeutic substitution: has its time arrived?
Hospital formulary. 19(9):834-5 ,838 [PMID] 10267930.
1983
Clinical pharmacy: two steps forward, one step back.
Drug intelligence & clinical pharmacy. 17(7-8):564-5 [PMID] 6872859.
1983
Formulary management through therapeutic substitution: factors behind the decision.
Hospital formulary. 18(10):956-61 [PMID] 10262827.
1982
A comparison of various types of patient instruction in the proper administration of metered inhalers.
Drug intelligence & clinical pharmacy. 16(1):53-5, 59 [PMID] 7053953.
1982
Physicians’ sources of information about teratogenic effects of drugs.
Drug information journal. 16(3):148-53 [PMID] 10259426.
1982
Therapeutic substitution practices in short-term hospitals.
American journal of hospital pharmacy. 39(6):1028-32 [PMID] 7102686.
1982
Trolamine salicylate cream in osteoarthritis of the knee.
JAMA. 247(9):1311-3 [PMID] 7038182.
1981
Rapid infusion of phenytoin sodium loading doses.
American journal of hospital pharmacy. 38(3):354-7 [PMID] 7223748.
1981
State regulatory positions concerning therapeutic substitutions in hospitals.
American journal of hospital pharmacy. 38(12):1900-3 [PMID] 7325169.
1981
Therapeutic substitution and the hospital formulary system.
American journal of hospital pharmacy. 38(12):1949-51 [PMID] 7325179.
1979
Nonpharmacy outlets providing prescription medications to ambulatory patients.
Contemporary pharmacy practice. 2(3):117-22 [PMID] 10242844.
1978
Contributions of a clinical pharmacist in a private group practice of physicians.
Drug intelligence & clinical pharmacy. 12(4):210-3 [PMID] 10307388.

Contact Details

Emails:
Addresses:
Business Mailing:
PO Box 100486
GAINESVILLE FL 32610
Business Street:
DEPT. OF PHARMACOTHERAPY AND TRANSLATIONAL R
DEPT. OF PHARMACOTHERAPY AND TRANSLATIONAL R
COLLEGE OF PHARMACY
GAINESVILLE FL 326110001